Agnieszka Szymczyk

Assessment of red blood cell distribution width as a prognostic marker in chronic lymphocytic leukemia

Monika Podhorecka, Dorota Halicka, Agnieszka Szymczyk et al. · Oncotarget · 2016 · 59 citations · Full text

Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer

Anna Krześlak, Ewa Forma, Paweł Jóźwiak et al. · Clinical and Experimental Medicine · 2012 · 46 citations · Full text

Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer

Anna Krześlak, Ewa Forma, Grażyna Chwatko et al. · Toxicology and Applied Pharmacology · 2013 · 38 citations

Urology, Gene Polymorphism, Human Polymorphism +6

Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population

Ewa Forma, Anna Krześlak, Jacek Wilkosz et al. · Cancer Genetics · 2012 · 34 citations

Urology, Cancer Risk, Cancer Epidemiology +9

Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number

Monika Podhorecka, Aneta Gorący, Agnieszka Szymczyk et al. · Oncotarget · 2017 · 34 citations · Full text